PL368565A1 - Use of compounds for treating conditions resulting from injury to the corneal nerve after lasik and other ocular surgeries or trauma - Google Patents
Use of compounds for treating conditions resulting from injury to the corneal nerve after lasik and other ocular surgeries or traumaInfo
- Publication number
- PL368565A1 PL368565A1 PL02368565A PL36856502A PL368565A1 PL 368565 A1 PL368565 A1 PL 368565A1 PL 02368565 A PL02368565 A PL 02368565A PL 36856502 A PL36856502 A PL 36856502A PL 368565 A1 PL368565 A1 PL 368565A1
- Authority
- PL
- Poland
- Prior art keywords
- lasik
- trauma
- injury
- compounds
- treating conditions
- Prior art date
Links
- 208000014674 injury Diseases 0.000 title 2
- 208000027418 Wounds and injury Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 230000006378 damage Effects 0.000 title 1
- 210000005036 nerve Anatomy 0.000 title 1
- 238000001356 surgical procedure Methods 0.000 title 1
- 230000008733 trauma Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31565201P | 2001-08-29 | 2001-08-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL368565A1 true PL368565A1 (en) | 2005-04-04 |
Family
ID=23225436
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL02368565A PL368565A1 (en) | 2001-08-29 | 2002-07-23 | Use of compounds for treating conditions resulting from injury to the corneal nerve after lasik and other ocular surgeries or trauma |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1420791A4 (en) |
| JP (1) | JP2005502678A (en) |
| CN (1) | CN1549718A (en) |
| AR (1) | AR036194A1 (en) |
| BR (1) | BR0212151A (en) |
| CA (1) | CA2455896A1 (en) |
| MX (1) | MXPA04001255A (en) |
| PL (1) | PL368565A1 (en) |
| WO (1) | WO2003020281A1 (en) |
| ZA (1) | ZA200400837B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE525111T1 (en) * | 2003-04-18 | 2011-10-15 | Senju Pharma Co | 2-CHLORO-6,7-DIMETHOXY-N-5 Ä5-(1)H-INDAZOLYLUQUINAZOLINE-4-AMINE, N-(1-BENZYL-4-PIPERIDINYL)-1H-INDAZOLE-5-AMINE DIHYDROCHLORIDE, 4-Ä2 -(2,3,4,5,6- |
| ES2234428B1 (en) * | 2003-12-09 | 2006-11-01 | Universidad Miguel Hernandez | COMPOUNDS FOR THE TREATMENT OF THE DROUGHT OF THE OCULAR SURFACE CAUSED BY THE PHOTO-REFRECTIVE SURGERY. |
| KR20070036031A (en) * | 2004-04-23 | 2007-04-02 | 센주 세이야꾸 가부시키가이샤 | Corneal Neuron Formation Promoters Containing PAC and Derivatives thereof |
| WO2005118582A1 (en) | 2004-06-03 | 2005-12-15 | Senju Pharmaceutical Co., Ltd. | Corneal perception recovery drug containing amide compound |
| EP2266559A1 (en) | 2005-03-15 | 2010-12-29 | Ono Pharmaceutical Co., Ltd. | Therapeutic agent for ophthalmic disease |
| CN113350326B (en) * | 2021-07-28 | 2023-03-17 | 爱尔眼科医院集团股份有限公司 | Application of compound LM22B-10 in preparation of corneal epithelium and nerve injury treatment drugs |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5166317A (en) * | 1988-10-31 | 1992-11-24 | Houston Biotechnology Incorporated | Neurotrophic factor |
| FR2672213B1 (en) * | 1991-02-05 | 1995-03-10 | Sanofi Sa | USE OF 4- (3-TRIFLUOROMETHYLPHENYL) -1,2,3,6-TETRAHYDROPYRIDINIC DERIVATIVES AS SENSORS OF FREE RADICALS. |
| US5767079A (en) * | 1992-07-08 | 1998-06-16 | Celtrix Pharmaceuticals, Inc. | Method of treating ophthalmic disorders using TGF -β |
| US5604244A (en) * | 1995-06-07 | 1997-02-18 | Alcon Laboratories, Inc. | Intraocular irrigating solution containing a polyamine antagonist |
| TWI246421B (en) * | 1998-12-03 | 2006-01-01 | Alcon Mfg Ltd | Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases |
| WO2001085152A2 (en) * | 2000-05-10 | 2001-11-15 | Alcon, Inc. | R-eliprodil for treating glaucoma |
-
2002
- 2002-07-23 BR BR0212151-4A patent/BR0212151A/en not_active Application Discontinuation
- 2002-07-23 JP JP2003524588A patent/JP2005502678A/en not_active Withdrawn
- 2002-07-23 MX MXPA04001255A patent/MXPA04001255A/en not_active Application Discontinuation
- 2002-07-23 WO PCT/US2002/023871 patent/WO2003020281A1/en not_active Ceased
- 2002-07-23 PL PL02368565A patent/PL368565A1/en unknown
- 2002-07-23 CN CNA028168682A patent/CN1549718A/en active Pending
- 2002-07-23 CA CA002455896A patent/CA2455896A1/en not_active Abandoned
- 2002-07-23 EP EP02756710A patent/EP1420791A4/en not_active Withdrawn
- 2002-07-30 AR ARP020102872A patent/AR036194A1/en unknown
-
2004
- 2004-02-02 ZA ZA200400837A patent/ZA200400837B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR0212151A (en) | 2004-08-24 |
| EP1420791A1 (en) | 2004-05-26 |
| CA2455896A1 (en) | 2003-03-13 |
| ZA200400837B (en) | 2005-02-02 |
| WO2003020281A1 (en) | 2003-03-13 |
| EP1420791A4 (en) | 2004-09-15 |
| JP2005502678A (en) | 2005-01-27 |
| CN1549718A (en) | 2004-11-24 |
| AR036194A1 (en) | 2004-08-18 |
| MXPA04001255A (en) | 2004-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1592435A4 (en) | Ophthalmic formulation for the prevention and treatment of ocular conditions | |
| WO2006071548A3 (en) | Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases | |
| WO2006066103A3 (en) | Ophthalmic implant for treatment of glaucoma | |
| GB2402674B (en) | Compositions and methods for the treatment of glaucoma or ocular hypertension | |
| EP1392292A4 (en) | Pyranoindazoles and their use for the treatment of glaucoma | |
| DE60045048D1 (en) | Scleral prosthesis for the treatment of hyperopia and other eye diseases | |
| HUP0401605A3 (en) | Integrin inhibitors for the treatment of eye diseases | |
| AU6391000A (en) | Method of preventing the injury or death of retinal cells and treating ocular diseases | |
| HK1038694A1 (en) | Antibiotic compositions for treatment of the eye, ear and nose | |
| HU0002963D0 (en) | Methods and compositions for treating diseases and conditions of the eye field of invention | |
| WO2002079149A3 (en) | Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases | |
| AU3840802A (en) | Methods and compositions for the treatment of diseases of the eye | |
| WO2000066139A3 (en) | Biochemical methods that eliminate corneal scars, opacification and haze | |
| AU2001256855A1 (en) | Preparation for the prevention and treatment of ocular disorders | |
| EP1420791A4 (en) | Use of compounds for treating conditions resulting from injury to the corneal nerve after lasik and other ocular surgeries or trauma | |
| ATE443060T1 (en) | BENZOAQUINOLINE DERIVATIVES FOR THE TREATMENT OF GLAUCOMA AND MIOPSIGHTEDNESS | |
| EP1482922A4 (en) | Agents for corneal or intrastromal administration to treat or prevent disorders of the eye | |
| CA2414586A1 (en) | Agent for therapeutic treatment of optic nerve diseases and the like | |
| EP1455780A4 (en) | Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma | |
| ZA200400210B (en) | Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases | |
| AU2002361516A1 (en) | Ophthalmic rofecoxib suspension for the treatment of ocular pain and inflammation | |
| AU4114301A (en) | Treatment of ocular hypertension and glaucoma | |
| MXPA04002098A (en) | Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma. | |
| IL163938A0 (en) | Agents for corneal or intrastromal administration to treat or prevent disorders of the eye | |
| TWI345980B (en) | Pharmaceutical compositions for preventing or treating injuries of brain tissue |